Utilized for restless legs syndrome to alleviate physical symptoms and support neurological control.
Mechanism of Action
Ropinirole is a non-ergoline dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D2 and D3 dopamine receptor sub-types, effectively mimicking dopamine activity in the brain.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
6 hours (half-life)
Contraindications
Hypersensitivity to ropinirole, Severe renal impairment
Severe Adverse Events
Sudden sleep onset, Hallucinations, Impulse control disorders — requires immediate medical attention
Information related to Ropinirole is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
